Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory D Huhn

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Emerging Infectious Diseases|December 2, 2005
Myocarditis Outbreak among Adults, Illinois, 2003Gregory D Huhn, Cindy Gross, David Schnurr, et al.
Journal of Travel Medicine|August 10, 2005
Outbreak of travel-related pontiac fever among hotel guests illustrating the need for better diagnostic testsGregory D Huhn, Barb Adam, Roger Ruden, et al.
The Journal of Infectious Diseases|August 31, 2006
Clinical manifestations of human monkeypox influenced by route of infectionMary G Reynolds, Krista L Yorita, Mathew J Kuehnert, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2013
Characterization of CD4⁺ T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patientsAimee C Hodowanec, Kirsten E Brady, Weihua Gao, et al.
Open Forum Infectious Diseases|January 18, 2020
Atherosclerotic Cardiovascular Disease Risk Profile of Tenofovir Alafenamide Versus Tenofovir Disoproxil FumarateGregory D Huhn, David J Shamblaw, Jean-Guy Baril, et al.
Vaccine|September 27, 2005
Vaccination coverage survey versus administrative data in the assessment of mass yellow fever immunization in internally displaced persons--Liberia, 2004Gregory D Huhn, Jennifer Brown, William Perea, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 28, 2019
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Rapid-Initiation Model of Care for Human Immunodeficiency Virus Type 1 Infection: Primary Analysis of the DIAMOND StudyGregory D Huhn, Gordon Crofoot, Moti Ramgopal, et al.
HIV Research & Clinical Practice|February 2, 2021
Week 96 subgroup analyses of the phase 3, randomized AMBER and EMERALD trials evaluating the efficacy and safety of the once daily darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) single-tablet regimen in antiretroviral treatment (ART)-naïve and -experienced, virologically-suppressed adults living with HIV-1Gregory D Huhn, Aimee Wilkin, Cristina Mussini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2005
Clinical characteristics of human monkeypox, and risk factors for severe diseaseGregory D Huhn, Audrey M Bauer, Krista Yorita, et al.
The Journal of Infectious Diseases|January 6, 2018
Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C VirusMichael Reid, Yifei Ma, Rebecca Scherzer, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Emerging Infectious Diseases|December 2, 2005
Myocarditis Outbreak among Adults, Illinois, 2003Gregory D Huhn, Cindy Gross, David Schnurr, et al.
Journal of Travel Medicine|August 10, 2005
Outbreak of travel-related pontiac fever among hotel guests illustrating the need for better diagnostic testsGregory D Huhn, Barb Adam, Roger Ruden, et al.
The Journal of Infectious Diseases|August 31, 2006
Clinical manifestations of human monkeypox influenced by route of infectionMary G Reynolds, Krista L Yorita, Mathew J Kuehnert, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2013
Characterization of CD4⁺ T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patientsAimee C Hodowanec, Kirsten E Brady, Weihua Gao, et al.
Open Forum Infectious Diseases|January 18, 2020
Atherosclerotic Cardiovascular Disease Risk Profile of Tenofovir Alafenamide Versus Tenofovir Disoproxil FumarateGregory D Huhn, David J Shamblaw, Jean-Guy Baril, et al.
Vaccine|September 27, 2005
Vaccination coverage survey versus administrative data in the assessment of mass yellow fever immunization in internally displaced persons--Liberia, 2004Gregory D Huhn, Jennifer Brown, William Perea, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 28, 2019
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Rapid-Initiation Model of Care for Human Immunodeficiency Virus Type 1 Infection: Primary Analysis of the DIAMOND StudyGregory D Huhn, Gordon Crofoot, Moti Ramgopal, et al.
HIV Research & Clinical Practice|February 2, 2021
Week 96 subgroup analyses of the phase 3, randomized AMBER and EMERALD trials evaluating the efficacy and safety of the once daily darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) single-tablet regimen in antiretroviral treatment (ART)-naïve and -experienced, virologically-suppressed adults living with HIV-1Gregory D Huhn, Aimee Wilkin, Cristina Mussini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2005
Clinical characteristics of human monkeypox, and risk factors for severe diseaseGregory D Huhn, Audrey M Bauer, Krista Yorita, et al.
The Journal of Infectious Diseases|January 6, 2018
Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C VirusMichael Reid, Yifei Ma, Rebecca Scherzer, et al.
Pageof 4